Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India [1]

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 4, 2005, Pages 1660-1661

  Dutta, Shanta ^a   Kawamura, Yoshiaki ^b   Ezaki, Takayuki ^b   Balakrish Nair, Gopinath ^c   Iida, Ken Ichiro ^d   Yoshida, Shin Ichi ^d  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^b GIFU UNIVERSITY   (Japan)

^c INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE IV; NALIDIXIC ACID; NORFLOXACIN; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; GENE MUTATION; GYRA GENE; GYRB GENE; GYRC GENE; HUMAN; INDIA; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARE GENE; PRIORITY JOURNAL; SHIGELLA DYSENTERIAE;

ANTI-INFECTIVE AGENTS; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; DYSENTERY, BACILLARY; FLUOROQUINOLONES; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS, DNA; SHIGELLA DYSENTERIAE;

EID: 16244375205     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.4.1660-1661.2005     Document Type: Letter

References (15)

1. Dutta, S., D. Dutta, P. Dutta, S. Matsushita, S. K. Bhattacharya, and S. I. Yoshida. 2003. Shigella dysenteriae serotype 1, Kolkata, India. Emerg. Infect. Dis. 9:1471-1474.
2. Ghosh, A. S., J. Ahamed, K. K. Chauhan, and M. Kundu. 1998. Involvement of an efflux system in high-level fluoroquinolone resistance of Shigella dysenteriae. Biochem. Biophys. Res. Commun. 242:54-56.
3. Heisig, P., H. Schedletzky, and H. Falkenstein-Paul. 1993. Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 37:696-701.
4. Heisig, P. 1996. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 40:879-885.
5. Maxwell, A. 1992. The molecular basis of quinolone action. J. Antimicrob. Chemother. 30:409-414.
6. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed., vol. 20, no. 2. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
7. Oethinger, M., I. Podglajen, W. V. Kern, and S. B. Levy. 1998. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob. Agents Chemother. 42:2089-2094.
8. Pal, S. C., P. G. Sengupta, D. Sen, S. K. Bhattacharya, and B. C. Deb. 1989. Epidemic shigellosis due to Shigella dysenteriae type 1 in South Asia. Ind. J. Med. Res. 89:57-64.
9. Pazhani, G. P., B. Sarkar, T. Ramamurthy, S. K. Bhattacharya, Y. Takeda, and S. K. Niyogi. 2004. Clonal multidrug-resistant Shigella dysenteriae type 1 strains associated with epidemic and sporadic dysenteries in eastern India. Antimicrob. Agents Chemother. 48:681-684.
10. Rahaman, M., G. Mauff, J. Levy, M. Couturier, G. Pulverer, N. Glasdorff, and J. P. Butzler. 1994. Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR. Antimicrob. Agents Chemother. 38:2488-2491.
11. Sen, D., P. Dutta, B. C. Deb, and S. C. Pal. 1988. Nalidixic acid resistant Shigella dysenteriae type 1 in eastern India. Lancet 2:911.
12. Talukder, K. A., B. K. Khajanchi, M. A. Islum, D. K. Dutta, Z. Islam, A. Safe, G. Y. Khan, K. Alam, M. A. Hossain, S. Malla, S. K. Niyogi, M. Rahman, H. Watanabe, G. B. Nair, and D. A. Sack. 2004. Genetic relatedness of ciprofloxacin resistant Shigella dysenteriae type 1 isolated in south Asia. J. Antimicrob. Chemother. 54:730-734.
13. Vila, J., J. Ruiz, F. Marco, A. Barcelo, P. Goni, E. Giralt, and T. J. D. Anta. 1994. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob. Agents Chemother. 38:2477-2479.
14. Vila, J., J. Ruiz, P. Goni, and T. J. D. Anta. 1996. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 40:491-493.
15. Wang, H., J. L. Dzink-Fox, M. Chen, and S. B. Levy. 2001. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutation. Antimicrob. Agents Chemother. 45:1515-1521.